Opendata, web and dolomites

OCTAV SIGNED

A novel approach to non-invasive and personalized skin cancer diagnosis

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 OCTAV project word cloud

Explore the words cloud of the OCTAV project. It provides you a very rough idea of what is the project "OCTAV" about.

practices    situ    market    company    computer    assist    platform    covered    margins    clinicians    fewer    cancers    definitive    melanoma    releasing    issue    validation    resolution    dermatological    presurgical    image    recurrence    oct    changing    benign    invasive    industrialization    diagnosis    detection    interpretation    routine    atlas    correlatively    feasibility    skin    medical    sme    risk    trl9    damae    lc    conjunction    accurate    dermoscopy    consolidated    telepathology    octav    consisting    segment    performant    cancer    diagnostic    full    french    2017    aided    services    first    optical    images    layers    patient    earlier    public    scars    imaging    unnecessarily    scaleup    designed    handling    paradigm    disruptive    trl6    cloud    cellular    storage    confocal    dermatologists    coherence    tomography    regulatory    successfully    instrument    initially    software    preventing    reducing    larger    approval    prototype    healthcare    private    lesions    solution    device    worldwide    data    line    adoption    financial    surgery    clinical    burden    capture    guide    biopsies    ing    phase2    deploying   

Project "OCTAV" data sheet

The following table provides information about the project.

Coordinator
DAMAE MEDICAL 

Organization address
address: BATIMENT 503 - CAMPUS SCIENTIFIQUE D'ORSAY
city: ORSAY
postcode: 91400
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country France [FR]
 Total cost 3˙485˙857 €
 EC max contribution 2˙400˙000 € (69%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-2
 Funding Scheme SME-2
 Starting year 2019
 Duration (year-month-day) from 2019-09-01   to  2021-08-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    DAMAE MEDICAL FR (ORSAY) coordinator 2˙400˙000.00

Map

 Project objective

French SME-company DAMAE Medical is facing skin cancer worldwide issue by developing the OCTAV Project, a new approach to dermatological diagnostic based on a disruptive Line-field Confocal Optical Coherence Tomography (LC-OCT) technology, in a novel hand-held imaging device. OCTAV is designed to capture in situ images of the skin layers with a cellular resolution. It is used in conjunction with dermoscopy to provide more accurate diagnosis, leading to fewer biopsies of benign lesions and earlier detection of melanoma (clinical use 1) and non-melanoma skin cancers (clinical use 2). It may also guide the surgery to provide more accurate presurgical margins (clinical use 3), preventing unnecessarily large scars and reducing the risk of recurrence. Correlatively, DAMAE is developing a full software solution, based on a data storage cloud-platform, a computer-aided software designed to assist dermatologists with OCTAV image interpretation, as well as telepathology and patient services. OCTAV device will initially be used by clinicians as a routine easy-handling diagnostic device in public practices (market segment 1). Implementation of OCTAV software will enable its adoption by a much larger market, consisting of private practices dermatologists (market segment 2). The approach will contribute to the development of skin cancer risk patient awareness, while changing the current paradigm through a timely, performant, and non-invasive approach, and releasing the financial burden on the healthcare system. Project OCTAV has successfully completed in 2017 a feasibility phase covered by the SME Instrument Phase 1, resulting in a TRL6 prototype of the technology and a first consolidated atlas of skin cancer clinical images. The main objective of this Phase2 is to scaleup the OCTAV solution to TRL9 through industrialization activities and by achieving a definitive market assessment, the clinical validation and the regulatory approval, before deploying the approach worldwide.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "OCTAV" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "OCTAV" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

COPI (2020)

Carbon Offset Plug-in

Read More  

SMART UV (2019)

Intelligent Ultraviolet (UV) Radiation Filters

Read More  

FOTOKITE-SME-P1 (2019)

Aerial Situational Awareness for Every Firefighter

Read More